RESMED INC — Director's Dealing 2015

Feb 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-02-13

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-13	ResMed Common Stock	M	100000	$15.52	Acquired	160913.385	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-13	ResMed NQ Stock Options	$15.52	M	100000	Disposed	2015-11-20	ResMed Common Stock (100000)	Direct

Footnotes

F1: This transaction represents the purchase hold price at the grant value of $15.52 per share.

F2: Represents date option first became exercisable.